Clinical negative predictors for pCR included sarcopenia, hypoalbuminemia, positive circumferential resection margin, clinical stage N2 and T4, tumor diameter > 5 cm, and CEA > 5 after treatment. This evidence concerns the gene CEACAM5 and sarcopenia.